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The Convention on Biological Diversity (CBD) is the first international agreement aiming at the conservation, 
sustainable development and fair and equitable benefit sharing out of use of biological resources. The Biological Diversity 
Act, 2002 (BDA) is India’s attempt to operationalize CBD. Some parts of this Act are ambiguous and keep a gap which may 
lead to misappropriation of genetic resources (GR) and traditional knowledge (TK). Section 3(p) of Patent Amendment Act, 
2005 makes the inventions using Indian traditional knowledge as non-patentable, but according to BDA the application for 
patent using Indian GR and/or TK is allowed (Section 6) while it is mandatory to get the permission from National 
Biodiversity Authority (NBA). Till 2010, 11 patents are granted based on approval of NBA. Another weak part is the 
exception of ‘normally traded commodities’ (NTC) from the provisions of BDA (Section 40), this provision leaves a 
potential chance for misappropriation of these GR and TK and no room is open for legal challenges. This article will try to 
do the analysis of BDA; it will consider how to clarify the ambiguity regarding patentability/non-patentability of inventions 
related to GR and associated TK and what is BDA’s role in prevention of misappropriation of Indian GR/TK by using 
intellectual property rights; it will discuss the vulnerability of NTC provision.  
Keywords: Convention on Biological Diversity, National Biological Authority, normally traded commodities, The 
Biological Diversity Act, 2002, biological resource, traditional Knowledge, genetic resources 
The Convention on Biological Diversity (CBD) is the 
first international agreement aiming at the conservation, 
sustainable development and fair and equitable 
benefit sharing out of use of biological resources. The 
Biological Diversity Act, 2002 (BDA) is India’s sole 
attempt to operationalize the provisions of CBD. To 
get proper conservation and sustainable development 
there is a need to analyse BDA in depth. This paper 
will enquire into the fact that whether some parts of 
this Act are ambiguous and keep a gap which may 
lead to misappropriation of Indian genetic resources 
(GR) and related traditional knowledge (TK).  
This article will consider how to clarify the 
ambiguity regarding patentability/non-patentability of 
inventions related to GR and associated TK and what 
is BDA’s role in prevention of misappropriation of 
Indian GR/TK by using intellectual property rights;  
it will discuss the vulnerability of ‘normally traded 
commodities’ (NTC) provision; it will also examine 
how far the BDA is transparent regarding benefit 
sharing with the traditional communities for their 
overall development and whether actual involvement of 
traditional communities in access and benefit sharing 
mechanism is ensured in BDA. 
India is rich in biological diversity and according to 
the CBD the State has the sovereign rights over their 
biological resources. Aim of BDA,  
as comparable to CBD, is conservation of Indian 
biological diversity, sustainable use of its components 
and fair and equitable benefit sharing. According  
to general understanding, sustainable use of the 
components of biological diversity is the mean to 
reach the goal of conservation of biodiversity. The 
third objective of fair and equitable benefit sharing is 
related with the commercialization of the biological 
diversity as a whole or part thereof. Indian biodiversity 
is used by Indian people since ages for their 
livelihood and usually ancient people used to use their 
resources (plant and animal) in such a way that 
objective of conservation was obtained. So, it can be 
said that, without knowing the terms ‘conservation’ 
and ‘sustainable use’ traditional people understood 
the need of it and used the components of biodiversity 
accordingly. It is the modern men with the initiation 
of industrialization started commodification and 
commercialization of everything, including components 
of biodiversity and started unlimited utilization of 
useful components. Situation become worse with the 
concept of intellectual property rights, which brings 
the private monopoly over the commodities.  
—————— 
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Issue of patent protection of inventions using 
components of biological diversity (which is an 
important component of our ecosystem and 
environment at large) should be handled with great 
care as patent monopoly may initiate unrestrained 
utilization of components of biodiversity leading to 
loss of balance in ecological system, hence the 
objective of sustainable use and conservation would 
be jeopardized. Next section will elaborate the Indian 
stand regarding this.  
 
Obtaining Patent on Genetic Resource or Associated 
Traditional Knowledge 
Indian Patent Amendment Act, 2005 has quite a few 
thoughtful provisions regarding issue of obtaining patent 
on inventions using biological diversity, genetic resource 
and associated traditional knowledge. 
 
Provisions of The Patents Act 
Section 3 of The Patents Amendment Act, 2005 
enlisted the non-patentable inventions and some of 
them can be used directly or indirectly for prohibition 
of obtaining patent on invention using biodiversity or 
genetic resource. Following are the provisions, 
i) If the invention is causing serious prejudice to 
human, plant or animal health or to the environment 
[Section 3(b)] - genetically modified plant or animal 
may cause serious harm for human health and/or for 
the environment, without proper risk assessment it 
could be dangerous to use; 
ii) The invention is actually discovery of any living 
thing occurring in nature [Section 3(c)] - any species 
of living plant or animal are thus non-patentable; 
iii) The invention is about a new form of a known 
substance or mere discovery of any new property or 
new use of a known substance [Section 3(d)] - a new 
mannose binding insecticidal lectin isolated from 
seeds of Annona is recently granted patent in India 
which is a mere discovery of a known substance as 
Annona is known for its insecticidal property for long 
time and used by traditional farmers; 
iv) The invention is obtained by a mere admixture 
resulting only in the aggregation of properties of the 
components of genetic resource [Section 3(e)] – 
herbal and medicinal plants of India are known and 
used for various therapeutic and cosmetic purposes, 
any new product or process of their making should 
not be patentable; 
v) The invention is about mere arrangement or re-
arrangement or duplication of known devices [Section 
3(f)] - Vaids and Hakims are using many devices for 
extraction, purification and preparation of traditional 
Ayurvedic medicine, those should not be the part of 
patentable invention;  
vi) The invention is a method of agriculture  
or horticulture [Section 3(h)] – any traditional methods 
of agriculture or horticulture should not be patentable 
as that will hamper the traditional agricultural activity 
and will give negative impact on our sustainable use and 
conservation of biodiversity; 
vii) The invention is about a method of treatment of 
human or animals [Section 3(i)] – traditional methods 
of treatment are thus non-patentable which includes 
huge number of plant and animal genetic resources; 
viii) The invention involves plants or animals 
(whole or their part) including seeds, varieties, species 
and essentially biologically processes for production 
or propagation of plant and animals [Section 3(j)]; 
ix) The invention involves a traditional knowledge 
or involves aggregation or duplication of traditionally 
known components of genetic resources [Section 3(p)] – 
wound healing property of turmeric or pesticidal extracts 
of neem components were not patentable, hence revoked 
abroad.  
Components of genetic resources or their known 
characteristics are in public domain, hence difficult to 
pass the novelty requirement of patentability criteria 
[Section 2(1)(j)]. The Controller has got the power to 
refuse to proceed with the application or may ask for 
the amendment to the application or specification or  
other documents if the application is not in compliance 
with the requirement of the Patent Act [Section 15]. 
Pre-grant and post-grant opposition is allowed for any 
invention using traditional knowledge [Section 
25(1)(k) and Section 25(2)(k)], or for any application 
whose complete specification is not disclosing or 
wrongfully disclosing the geographical origin of the 
used biological material [Section 25(1)(j) and Section 
25(2)(j)]. Post-grant opposition on these grounds  
may cause revocation of such faulty patent [Section 
64(1)(p) and Section 64(1)(q)]. These included provisions 
are making the Indian stand stronger for prevention of 
biopiracy and misappropriation of genetic resources 
and associated traditional knowledge. 
 
Provisions of Biodiversity Act, 2002 
Strict rules have been made in Biological Diversity 
Act, 2002 (BDA) regarding the application for any 
form of intellectual property right (IPR) for the 
inventions based on Indian biological resources. 
Section 6 deals with this provision and it prevents all 
Indian citizens as well as foreign nationals from 
applying for any form of IPR in India or abroad 
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unless the applicant get the prior approval from 
National Biodiversity Authority (NBA) [Section 6(1) 
& Rule 18]. Proviso for Section 6 said that instead of 
getting the permission before application of patent, 
the applicant can get the approval after acceptance of 
the patent but before sealing of patent by patent 
authority.  
As per the requirement of the patent application in 
Form 1, the applicant has to give the declaration that 
he/she will submit the necessary permission from the 
NBA before grant of patent [Clause 9(iii) of Form 1 
for Application for Grant of Patent]. Approval  
from NBA is a necessary requirement to stop the 
misappropriation of genetic resources of Indian 
origin. It is the duty of NBA to make proper enquiry 
regarding the application of any form of intellectual 
property right [Section 19(2)] and to consult with an 
‘expert committee’ regarding the issue [Section 19(3) 
of Biological Diversity Act, 2002]. The application 
fee needs to be collected by NBA; they can collect 
necessary additional information to judge the merit of 
the application and has to give a decision within 3 
month time period [Section 6(1), 2002 & Rule 18(3)].  
NBA can reject the application if the applicant 
failed to furnish necessary information to judge the 
merit, in that case the reasons has to be recorded and 
the applicant has to be provided with a chance to 
defend himself in a hearing in front of the Authority 
before rejection [Section 19(3) Act, 2002 & Rule 
18(6)]. It is also duty of NBA to supervise the 
intellectual property applications abroad regarding 
misappropriation of Indian biological resources and 
associated traditional knowledge which is obtained 
from India in an illegal manner and to take necessary 
measures to oppose those applications [Rule 12(xix)]. 
Any person applying for the protection of plant 
variety shall not take any permission from NBA, 
which means that breeders applying for the protection 
of new plant variety will not come under the provisions 
of Section 6 of BDA [Section 6(3)].  
 
Ambiguous Law and More Ambiguous Implementation 
According to Section 6 approval has to be taken 
from NBA before applying for the intellectual 
property in India or outside by the applicant, but the 
Act or the Rule never specifies the criteria according 
to which NBA will provide the necessary approval or 
reject the application for approval. In the website the 
latest Annual Report of NBA which is available is  
of the year 2009 – 2010, as per that Report NBA 
received 97 applications for approval for patent, 
among which 10 is cleared and rest 87 was in process. 
No detailed information is available in the Report or 
elsewhere in the website regarding those applications 
or based on what the applications were accepted  
or judged. Same Annual Report tells us that until  
31 March 2010 eleven patents were granted based  
on approval of NBA, Report provides the Application 
number, Applicant name and one line description of 
the invention. It is difficult to presume on what basis 
those approvals had been given.  
All these inventions supposedly involve commonly 
used biological material of Indian origin like fenugreek 
seed, annona, pineapple leaf etc. In spite of above 
mentioned provisions in Patents Act and Biological 
Diversity Act if so many patents are granted in India for 
inventions primarily using Indian biological resources, 
then the important question of proper implementation 
come into mind. In the next section one interesting case 
study will further elaborate the implementation failure 
on the part of NBA.  
 
Implementation Failure: Case Study 
NBA is under the statutory duty of supervising the 
intellectual property applications worldwide and to 
search out whether any biological material / genetic 
resource are utilised in any application in India or 
abroad. If any such circumstances appear, NBA has 
the power to take proper initiatives to oppose the 
grant of such intellectual property right in such 
country. Proper implementation of this power and 
discharge of the duty requires planning, motivation, 
and manpower.  
A query comes in the way about the role of NBA 
regarding discharge of its duty while discussing the 
interesting case of opposition of Monsanto’s European 
Patent (EP 1962578) on Clostero virus-resistant 
melon plant. A Dutch seed company, DeRuiter, used 
the variety of Indian melon to develop Cucurbit 
yellow stunting disorder virus (CYSDV) – resistant 
melon variety in 2008 to help farmers of North 
America, Europe and North Africa to prevent 
spreading of this virus in the melon plantation.
1
 
Cucurbit yellow stunting disorder virus (CYSDV) 
was endemically disseminated in North hemisphere of 
the world, and this CYSDV-resistant melon variety 
aided a lot to the melon farming communities. Later 
on Monsanto took over DeRuiter and they applied 
patent for the ‘invention’ of this virus-resistant variety 
of melon, the EPO granted the patent to Monsanto in 
May 2011. On 3 February 2012 Indian scientist  
and activist Dr. Vandana Shiva with the help of one 
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European NGO ‘No Patents on Seeds’ filed an 
opposition against this patent in European Patent 
Office.
1
 Dr. Shiva has mentioned that as DeRuiter or 
Monsanto has not taken the prior approval from NBA 
before applying for the patent for an invention using 
an Indian melon variety, which is mandatory as per 
Section 6 of BDA, they can be prosecuted for 
biopiracy.
2
 The shocking fact is that NBA, who is 
having statutory authority and duty to take proper 
action against anybody applying for any intellectual 
property rights for inventions involving Indian 
biological resources, are silent about this matter.  
Neither they have discharged their duty by proper 
supervision and initiate necessary action, nor have 
they tried to help Dr. Shiva and the NGO who were 
taking personal initiative for the larger societal 
interest. The question here is NBA being the 
government body and duty bound by the statute for 
protection of biological resource of Indian origin, the 
stand taken by them in this case is not only frustrating 
but also very alarming. India is an agricultural based 
country, innumerable farmers’ livelihood is related 
with the biological resources, and moreover the new 
trend of commodification and monopolisation of 
biological resources usually targets the country rich in 
biodiversity like India. Legal system is made by the 
lawmakers and implementation is given in the hand of 
a national authority, but if the authority is failed to 
discharge the duties properly they should face the 
rigid consequences as a result of what they should 
change the attitude. 
 
Access to Genetic Resource and Transfer of 
Knowledge 
NBA is the nodal authority (designated ‘competent 
national authority’ as required by CBD) in India to look 
after the protection of Indian biological resources. 
 
Duties of NBA  
It is also statutory duty of NBA to regulate the 
access of biological resources of Indian origin for any 
kind of research activity and also to regulate the 
transfer of result of such research activity with third 
parties. Legislation is clear enough to mention that ‘a 
person who is not a citizen of India; or a citizen of 
India who is a non-resident; or a body corporate, 
association or organization not incorporated or 
registered in India; or a body corporate, association 
or organization incorporated or registered in India 
which has any non-Indian participation in its share 
capital or management’has to take permission from 
NBA before obtaining any biological resource of 
Indian origin for any kind of research or for 
commercial utilization or bio-survey or bio-utilisation 
(Section 3 of Biological Diversity Act, 2002). It is 
also mentioned that nobody is permitted to transfer 
the result of any research on biological resources of 
Indian origin to these above mentioned persons or 
body corporates or associations or organizations 
(Section 4). ‘Transfer’ is explained in the statute in 
terms of certain exclusions, which are publication of 
research paper (according to the guideline issued by 
Central Government) or knowledge sharing in any 
seminar or workshop [Section 4 (Explanation)].  
For Indian citizens or Indian body corporate/ 
association/organization the prior approval clause is 
similarly applied before any commercial utilization, 
or bio-survey, or bio-utilization of Indian biological 
resources but that approval has to be taken from 
respective State Biodiversity Board (Section 7). 
Research activity in not included in the list of 
activities for which prior approval has to be taken,  
nor there is any restriction of transfer of research 
result to the other Indian citizens or body corporate/ 
association/organization of Indian origin.  
But in practical situation non-incorporation of 
research activity for Indian scientists or funded  
by body corporate/association/organization of Indian 
origin should not be a problem from misappropriation 
of biological resources as everybody has to get  
the prior approval before any commercialization or 
commodification of the research results or before 
transfer of such research result to any non-Indian 
citizen or to any body-corporate/association/ organization 
of non-Indian origin. This will be helpful if all the 
scientists, engaged in research activities related with 
Indian biological resources, strictly abide by the 
norms and rules made thereof.  
This is a grim fact that norms and rules are usually 
not been followed properly. The next section of this 
paper will elaborate the case of development of Bt 
brinjal using local indigenous brinjal varieties without 
any prior approval and bizarre response of NBA in the 
whole process.    
 
Failure to Discharge the Duty by NBA: Case Study 
It is an immense duty to NBA to supervise all 
illegal activity throughout India and take necessary 
measures. They have been given full authority,  
but with that authority usually come immense 
responsibility, now the questions will arise how much 
sincerely that responsibility is discharged. This issue 
will be discussed here with reference of the first ever 
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case on biopiracy in India by NBA, i.e. Mahyco-
Monsanto Bt Brinjal case. Monsanto, world’s biggest 
agro-biotechnology company with its Indian subsidiary 
Mahyco along with different public funded agricultural 
institute of India (University of Agricultural Sciences, 
Dharwar, Karnataka; Tamilnadu Agricultural University, 
Coimbatore, Tamilnadu; and Indian Institute of 
Vegetable Research, Uttar Pradesh) accessed about 
10-16 local brinjal varieties from Karnataka & 
Tamilnadu to produce genetically modified Bt brinjal 
variety,
3
 the whole research process was facilitated by 
Sathguru Foundation, Hyderabad, who was coordinating 
on behalf of United States Agency for International 
Development and Cornell University, New York.
3
 
This project was the direct outcome of the India-US 
bilateral Agreement called Knowledge Initiative  
on Agriculture (KIA), signed by US President  
Mr. George Bush and Indian Prime Minister  
Mr. Manmohan Singh on 18 July 2005.
4
  
Environment Support Group (ESG) had taken the  
first initiative to identify that Mahyco-Monsanto 
alliance is using indigenous brinjal varieties to 
produce genetically modified brinjal for the  
obvious commercial purposes but that had been done 
with non-compliance to BDA as they have not  
taken any prior approval before access the indigenous 
brinjal varieties.
5 
ESG activists worked tirelessly 
informing several authorities including Karnataka 
Biodiversity Board (KBB), Karnataka Chief  
Minister, NBA, Indian Prime Minister, and  
media to raise the voice against this biopiracy but they 
received bizarre response from KBB and NBA. NBA 
had to face harsh criticism from the government (from 
Lok Sabha’s Public Account Committee and 
Parliamentary Standing Committee on Agriculture).
6
 
Finally NBA lodged criminal case against all 
stakeholders and the case is in Karnataka High Court 
before the bench. Table 1 will show the gist of the 
efforts of ESG and the response with dates mentioned 
therewith.  
Following relevant questions will arise after  
careful investigation of all the facts of this case and 
NBA should take the responsibility to answer all these 
questions.  
Table ― 1 Time line of events for Mahyco-Monsanto Bt Brinjal case5 
S No. Event Date 
1 GEAC approval of Bt brinjal 14 October 2009 
2 Moratorium imposed by Ministry against Bt brinjal 9 February 2010 
3 ESG filed complaint to KBB (copying to NBA) 15 February 2010 
4 KBB 13th Board Meeting to enquire into the matter with University of Agriculture regarding whether it 
was a Govt. of India approved research project or the permission of NBA had been taken 
26 February 2010 
5 KBB forwarding the complaint of ESG to NBA 10March 2010 
1 KBB’s repeated request to NBA to initiate the proceedings  29 March 2010 
2 KBB’s repeated request to NBA to initiate the proceedings  12 April 2010 
3 KBB’s Report to NBA mentioning that 6 local brinjal varieties has been used without prior permission 
for the said project  
28 May 2011 
4 NBA decided to initiate the prosecution (more than one year and four months after the initial information 
by ESG  
20 June 2011 
5 KBB’s 18th Board Meeting: Decision to wait for further intimation or guidance from NBA regarding 
legal action; it was also decided that in future R&D and bio-safety trials on Bt crops in Karnataka would 
require KBB’s permission and communicated to Central Government 
14 September 2011 
6 NBA decided not to take any legal action (sudden change in their stand!) 22 November 2011 
7 KBB 19th Board Meeting: Clarified that the subject matter coming under purview of NBA, so NBA had 
to take necessary action 
20 January 2012 
8 NBA decision to initiate criminal prosecution against all relevant stakeholders (taken two years to finally 
start the proceedings) 
28 February 2012 
9 ESG filed RTI query to NBA 26 April 2012 
10 15th Lok Sabha’s Public Account Committee Report criticized NBA 27 April 2012 
11 NBA refused to give documents of the case to ESG 21 May 2012 
12 ESG representation of the issue to Karnataka CM 23 June 2012 
13 Parliamentary Standing Committee on Agriculture in their 37th Report criticised NBA for their stand  9 August 2012 
14 NBA Chairman released all the relevant documents to ESG 13 August 2012 
15 Writ Petition by ESG at Karnataka High Court against some issues in BDA October 2012 
16 Stay order by Karnataka HC in favour of accused regarding criminal proceedings 3 January 2013 
17 Karnataka vacated stay order and ordered NBA to continue criminal proceedings 11 October 2013 
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 How much safe is Indian biological diversity in 
the hand of NBA who is the nominated caretaker 
of protection of that? 
 How fair is NBA in discharging their duties 
towards Indian biological resources? 
 Why the responsible NGOs like Navdanya or 
ESG can’t expect NBA to support them even after 
locating the misappropriation and initiating 
protest against it? 
 Why there is internal contradiction in KBB’s decision 
in the timeline regarding their responsibility and 
authority towards a serious misdeed? 
 Why NBA wasted valuable two years (from 
ESG’s first complaint to KBB with copy to NBA 
on 15 February 2010 to NBA’s final decision of 
criminal prosecution on 28 Febrary 2012) in this 
case? 
 Why NGO has to push KBB and NBA (the national 
and state authorities who are duty bound) to 
discharge their duty and responsibility properly and 
to initiate necessary action against wrongdoers? 
 Why there is no communication and cooperation 
between different authorities (like GEAC and 
NBA for example) handing same or similar inter-
related and very sensitive issues like approval of 
GM crop development and use of indigenous 
crops for that purpose? 
Hopefully in future cases of biopiracy NBA will 
show the responsible behaviour and the answer of 
these questions will come forward. 
 
Exemptions in BDA and its Impact 
BDA provides certain exemptions to the rule of 
prior approval for access, or research or transfer of 
result. Certain group of people is mentioned in the 
statute for the exemptions that is depicted in Table 2.  
 
Rationale of Exemption to Collaborative Research Project 
Section 7 of BDA is carefully exempted the local and 
traditional community people whose livelihood is 
mainly based on biological resources surrounding them; 
traditional farmers who are helping the maintenance of 
diversity in biological resources by natural selection;  
and local Vaids & Hakims practising the indigenous 
medicine for years. But rationale of the exemption of 
scientists involved in collaborative research projects is 
not clarified in the statute. Section 5(1) says that the 
prior approval from NBA before access for research on 
biological resources or commercial utilization or transfer 
of research results will not be applicable for the 
“collaborative research projects involving transfer or 
exchange of biological resources or information 
relating thereto between institutions” if those 
collaborative projects are in compliance with the 
policy guidance issued by Central Government or 
approved by the Central Government. The institutes 
which may be involved in those projects can be 
Government Sponsored Institutions of India or of 
other countries. So the foreign institution engaged in 
the collaborative research project approved by Central 
Government can also claim the suggested exemption. 
Who will give the guarantee that the scientists of 
Government Sponsored Institutions of India or their 
foreign partners will not lead the mishandling of 
Indian biological resources and will not cause 
misappropriation for their own economic profit.  
Because of this exemption, NBA will have no 
control on unlimited access of any kind of biological 
resource or any commercial utilization of the end 
Table ― 2 Exemptions Provided in BDA 
S No. Exempted bodies Relevant Section of 
BDA 
Exempted from Not exempted from 
1. Local people & communities Section 7 Prior approval before access Prior approval before transfer 
of knowledge or application for 
IPRs 
2. Growers & cultivars of 
biodiversity 
Section 7 Prior approval before access Prior approval before transfer 
of knowledge or application for 
IPRs  
3. Vaids & Hakims Section 7 Prior approval before access Prior approval before transfer 
of knowledge or application for 
IPRs  
4. Collaborative research 
project 
Section 7 Prior approval before access, 
Commercial utilization & 
transfer of result 
Prior approval before 
application for IPRs  
5. Normally traded 
commodities 
Section 40 Prior approval before access 
for trading activities 
Prior approval before research 
or commercial activity or 
application for IPRs 
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products of the research using those resources. If a 
project is planned in compliance with the policy 
guideline of Central Government or approved by the 
Central Government, what is the assurance that those 
projects will not lead to biopiracy; and if something 
happens of that sort NBA being the whole sole 
authority will not have the right to intervene because 
of statutory exemption. 
In the above discussed Bt brinjal case of biopiracy, 
some intellectuals argued that scientists involved in 
that project should get the Section 5 immunity as the 
project resulted from a bilateral India-US Agreement 
on KIA, so it has to be taken as a government 
approved project.
7
 So the non-compliance with the 
prior approval before access of indigenous brinjal 
varieties is justified and the involved scientists should 
not face the criminal consequences. Matter is under 
Karnataka High Court now, though in January 2013 
High Court had given a stay order in favour of the 
Registrar, and former and present Vice-Chancellor of 
University of Agricultural Sciences, Dharwad, but 
after challenge by NBA and KBB Court had vacated 
the stay in October 2013 and stated NBA and KBB to 
continue the criminal proceedings against all the 
accused.
8
 It is not yet the situation that court has 
considered about the Section 5 immunity about the 
accused, but if that is considered then no criminal 
charges will be applied to them. Moreover, this may 
create a big loophole with the help of this statutory 
provision and may lead to more misappropriation or 
biopiracy regarding Indian biological resources. 
 
Rationale of Exemption for Normally Traded Commodities 
According to Section 40 of BDA Central 
Government has been given a special authority to 
provide complete immunity to some notified 
biological resources as ‘normally traded commodities’ 
(NTC) (by notification in the Official Gazette) from 
all the provisions of BDA. Ministry of Environment 
and Forests (MoE&F) had given the said notification 
on 26 October 2009 which declared a list of 190 
biological resources which will get the exemption 
from all provisions of BDA.
9
 The list is prepared 
based on the list of 190 names of biological resources 
identified by the ‘expert committee,’ which was  
set up by NBA in November 2005, after consultation 
with different government bodies and research 
organizations.
10
 MoE&F also provided a clarification 
(16 February 2010) regarding this notification,
10
 
which gives different comprehension about the 
statutory provisions. It is clearly mentioned in Section 
40 of BDA that “the provisions of this Act shall not 
apply to any items, including biological resources 
normally traded as commodities.” This gives an 
impression that Section 40 is providing all the 190 
notified biological resources the complete immunity 
from all the prior approval requirements, i.e. for 
access, for research, for commercial exploitation, for 
transfer of research result, and for application of 
intellectual property rights. But according to the 
clarification, it is understood that all the 190 items 
will get immunity for export only (so, for export of 
these items no prior approval is required from NBA), 
but the prior approval has to be obtained for using the 
biological resources in any research or industrial 
activity as per the requirement of BDA. By simple 
understanding, it will be difficult for Indian 
authorities to supervise the forbidden activities (such 
as research and industrial utilization) by foreign 
entities once unregulated access is provided for all 
these 190 notified items. ESG had shown their 
concern about this issue in their Writ Petition to 
Karnataka High Court. ESG mentioned that they have 
reviewed the list carefully and found 15 plants of that 
list is already included in the officially declared list of 
threatened and/or critically endangered species by 
International Union for Conservation of Nature 
(IUCN) and the Convention on International Trade in 
Endangered Species of Wild Fauna and Flora, 1973 
(CITES Convention). Table 3 provides some 
important examples in this regard.  
Vulnerable/threatened/endangered species of 
Indian biological diversity should be a huge  
concern for the MoE&F, concern is reflected in  
Rule 16 of Biological Diversity Rules, 2004 which 
has mentioned about special restrictions regarding the 
following requests: 
(i) the request for access is for any endangered taxa; 
(ii) the request for access is for any endemic and rare 
species; 
(iii) the request for access may likely to result in 
adverse effect on the livelihoods of the local 
people; 
(iv) the request to access may result in adverse 
environmental impact which may be difficult to 
control and mitigate; 
(v) the request for access may cause genetic erosion 
or affecting the ecosystem function; 
(vi) the request for use of resources for purposes 
contrary to national interest and other related 
international agreements entered into by India. 
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Same concern is conformed in the clarification 
given by Mr. Jairam Ramesh (the then Minister of 
Environment & Forests) on 16 February 2010 as it 
specifically mentioned about special restrictions 
regarding the same issues as per provisions of Rule 
16. Even stronger motivation was reflected in that 
clarification as it said about the preparation of  
State-wise list of endangered/vulnerable species  
along with the guideline for their rehabilitation.  
Such species had been already notified for the  
states of Himachal Pradesh (19 March 2009), 
Uttarakhand (23 April 2009), Uttar Pradesh (23 April 
2009), Kerala (23 April 2009), Odissa (05 October 
2009), Mizoram (05 October 2009), and Meghalaya 
(05 October 2009). Till date there is no further 
amended notification from MoE&F regarding revised 
list of NTCs. If such thoughtful steps have been taken 
by MoE&F since last four years, the usual question 
comes in mind that why there is no revision of the list 
of NTC till now and with unregulated trade of these 
items will take how long to increase the number of 
species in the list of endangered/vulnerable species in 
each and every state of India.  
 
Conclusion 
Historically all mega-biodiverse countries are 
exploiting there biological diversity since time 
immemorial, but never that exploitation went beyond 
a certain limit. Commodification started later on along 
the time line, but unless very recent years, not until 
the concept of intellectual property rights take a steep 
ride, the commercialization and commodification of 
biological resources have gone up to a level of beyond 
limit. Specifically after mandatory implementation  
of TRIPS Agreement the aggressiveness of getting 
monopoly over inventions based on biological 
resources have increased by huge extent. Research 
aimed for the purpose of commercial utilization 
augmented in such a way, specially by the multinational 
IPR oriented biotechnological research and development 
companies, that rules and regulation has become 
urgently necessary to get control over every such 
activity. Not many people are actually concerned about 
the fact that in spite of international and national legal 
rules and regulations there is lot of unregulated and 
unethical practices going on regarding access and 
commercial exploitation of the biological resources and 
associated traditional knowledge. Awareness and 
capacity building at every level, even up to the grass root 
level is one of the ways to prevent or at least restrict 
unlimited access for the variety of purposes.  
Certain volume of biodiversity loss had already 
happened; the goal now should be to prevent the 
further loss, so that the future generation can be 
saved. It needs to be remembered that the impact of 
loss of biological diversity is vast; which may cause 
disturbance of balance in ecosystem, loss of food  
and cash crops, problem in agriculture as such and 
industry based on agriculture as well. The effect of 
that may endanger the very existence of human 
civilisation, our ignorance and carelessness will 
aggravate and accelerate the danger very soon. This is 
the right time to be careful about the situation and 
NBA being the designated authority, should take the 
lead role in the regulated access of Indian biological 
diversity by using the statutory model of BDA and 
amending the less clarified and ambiguous part of it 
with involvement of law making authorities.  
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